Drug
Tirofiban clinical trials
Also written Aggrastat and Agrastat.
- studies test it
- 47
- open now
- 15
- in phase 3
- 17
- first study started
- 2003
Keep track of what changes. Save the Tirofiban studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
46 studies that test it; most in 2024 (7)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 15
- Phase 3
- 17
- Phase 4
- 17
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 43
Xinqiao Hospital of Chongqing (3) · Beijing Tiantan Hospital (3) · Medicure (3) · Capital Medical University (3) · Beijing Anzhen Hospital (2) · The First Affiliated Hospital of Zhengzhou University (2) · Peking Union Medical College Hospital (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)
Often tested with
Tested in the same studies.
Sodium nitroprusside anhydrous (2) · Nitroprusside (2) · Clopidogrel (1) · Aspirin (1) · Fondaparinux (1)
Studies
Open first, then newest update. How each study uses Tirofiban is read from its arms, and is right about nine times in ten.
Testing it · 47
- Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)Not yet recruitingPhase 1/2Dr David Hasan, M.D.NCT07493577Written as Tirofiban
- A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic StrokeNot yet recruitingPhase 2/3Xinqiao Hospital of ChongqingNCT07842185Written as Tirofiban Injection
- Tirofiban Combined With Aspirin in Moderate Ischemic StrokeNot yet recruitingPhase 4Xinqiao Hospital of ChongqingNCT07760922Written as Tirofiban
- HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)RecruitingPhase 3Weifang Medical UniversityNCT07379190Written as Tirofiban
- Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel OcclusionNot yet recruitingPhase 3Shandong Provincial HospitalNCT07537933Written as Tirofiban
- Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery OcclusionNot yet recruitingPhase 3Beijing Tiantan HospitalNCT07335107Written as Intravenous Tirofiban
- Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic StrokeRecruitingNot applicableThe First Hospital of Jilin UniversityNCT06045156Written as Tirofiban
- Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic StrokeRecruitingPhase 3Second Affiliated Hospital of Guangxi Medical UniversityNCT05604638Written as Tirofiban Hydrochloride
- Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic StrokeRecruitingPhase 4Beijing Anzhen HospitalNCT07290751Written as Tirofiban
- Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic StrokeRecruitingNot applicableBeijing Anzhen HospitalNCT07026318Written as Tirofiban
- Intravenous Tirofiban After Delayed Thrombolysis in StrokeNot yet recruitingPhase 3Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07111806Written as Tirofiban
- No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the TrackRecruitingNot applicableKafrelsheikh UniversityNCT06966674Written as Intracoronary tirofiban
- Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic StrokeNot yet recruitingPhase 2/3Capital Medical UniversityNCT06587347Written as Tirofiban Hydrochloride
- Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）RecruitingPhase 3Beijing Tiantan HospitalNCT06319846Written as Tirofiban
- Tirofiban for Successful Endovascular Stroke ThrombectomyNot yet recruitingPhase 2/3Zhongming QiuNCT06373042Written as Intraarterial and intravenous tirofiban
- Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in StrokeCompletedPhase 2/3Xinqiao Hospital of ChongqingNCT05728333Written as Tirofiban
- Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)CompletedPhase 3Peking Union Medical College HospitalNCT06037889Written as Tirofiban
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem LesionCompletedPhase 4Fundación Pública Andaluza para la gestión de la Investigación en SevillaNCT05225961Written as Tirofiban
- Tirofiban After Successful MT Recanalization in AISCompletedPhase 2/3Xiang LuoNCT06265051Written as Tirofiban
- Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm RepairCompletedPhase 2/3Beijing Tiantan HospitalNCT06238115Written as Tirofiban
See all 47 studies that test Tirofiban →
Given in every arm · 1 — Tirofiban is usual care beside what is tested
As the comparator · 7 — what is tested is compared with Tirofiban
- Intracoronary rhTNK-tPA Versus Tirofiban in Patients With STEMI and High Thrombus BurdenRecruitingPhase 4Henan Institute of Cardiovascular EpidemiologyNCT06769256Written as Tirofiban
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.CompletedPhase 4Insel Gruppe AG, University Hospital BernNCT02978040Written as Tirofiban
- Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial InfarctionCompletedPhase 4Fudan UniversityNCT02131220Written as Tirofiban
- BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.CompletedPhase 4Shenyang Northern HospitalNCT01696110Written as heparin plus tirofiban
- Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary SyndromeStatus unknownPhase 3Pusan National University Yangsan HospitalNCT01660373Written as Tirofiban
- Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOseCompletedPhase 3Università degli Studi di FerraraNCT01336348Written as Tirofiban
- Tirofiban and Enoxaparin in High Risk Coronary InterventionCompletedPhase 4The Prince Charles HospitalNCT00790387Written as Tirofiban
Codes
What other systems call Tirofiban · ClinicalTrials.gg INT006731
- MeSH (NLM) D000077466TirofibanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GGX234SI5HTIROFIBANConfirmed FDA, NLM, Wikidata
- RxNorm 73137Confirmed FDA, Wikidata
- Wikidata Q415366tirofibanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76405TirofibanOne source FDA
- DrugBank DB00775One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077466 | Tirofiban | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GGX234SI5H | TIROFIBAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 73137 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415366 | tirofiban | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76405 | Tirofiban | One source FDA |
| DrugBank | DB00775 | — | One source Wikidata |
Also registered as tirofiban hydrochloride (UNII 6H925F8O5J · RxNorm 253202).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.